搜索临床试验以:Cancer Risk
总计98465个结果
-
Point Therapeutics终止
-
French Innovative Leukemia Organisation完全的
-
Skane University HospitalSwedish Cancer Society; Europe Against Cancer (European Union Directorate General XII- Public...完全的
-
Santa Casa de Passos终止
-
Finnish Breast Cancer GroupSanofi; Hoffmann-La Roche; AstraZeneca完全的
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; Mackay Memorial Hospital; China Medical University Hospital; Chang Gung Memorial Hospital 和其他合作者未知
-
PfizerDiabetes UK; Department of Health, United Kingdom完全的心绞痛,不稳定 | 脑血管意外 | 冠状动脉搭桥术 | 血运重建 | 主要冠状动脉事件英国
-
Trans Tasman Radiation Oncology GroupCancer Council New South Wales完全的
-
University of GiessenNovartis; Hoffmann-La Roche; Astellas Pharma Inc; Heidelberg University; Fresenius AG; Biotest完全的
-
Central Institute of Mental Health, MannheimGerman Federal Ministry of Education and Research完全的
-
Wyeth is now a wholly owned subsidiary of Pfizer完全的肾同种异体移植物接受者
-
Seattle Cancer Treatment and Wellness Center未知
-
University of TorontoAlmond Board of California; Unilever R&D; Natural Sciences and Engineering Research Council, Canada 和其他合作者完全的
-
Pharmacyclics LLC.完全的
-
NovaceaAventis Pharmaceuticals完全的